Drug intelligence / Profile preview

N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine

Development stage: Unknown
Modality: Small Molecules

Overview

N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine is a synthetic small molecule belonging to the class of n-acyl-alpha amino acids. It features a D-alanine residue acylated with a 4-(4-nitrophenylphospho)butanoyl group. The compound is primarily of interest as an experimental chemical entity and does not have any approved therapeutic indications or known clinical use. Its mechanism of action and biological targets are not described in available databases. There are no reported clinical trials or marketed products containing this compound[1][2][3][4].

Other names: N-[4-(4-nitrophenylphospho)butanoyl]-D-alanineN-[4-(4-nitrophenylphospho)butyryl]-D-alaninep-nitrophenyl phosphonobutanoyl D-alanine

Beyond the preview

Go deeper on N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine.

Explore the full profile